Premium Information is available for this item - Upgrade for $1 a day
6505-01-308-9409
Usp Nortriptyline Hydrochloride Capsules
6505013089409 013089409 PAMELOR NDC00078-0078-06
May 2023
8
Marketplace 6505-01-308-9409
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-308-9409 5+ Documents (More...)
PAMELOR CAPSULES NDC00078-0079-05 Managed by United States NSN Created on 5 May 1987 Data Last Changed
your Account Upgrade 6505-01-308-9409Usp Nortriptyline Hydrochloride Capsules6505013089409 013089409
//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-083-5987 Usp Nortriptyline Hydrochloride Capsules PAMELOR
197-9381 903-7080 6505-01-214 Usp Nortriptyline Hydrochloride Capsules Equivalent [THPE]Pamelor 197-
PAMELOR CAPSULES NDC51672-4001-01 NDC00093-0810-01 Managed by United States NSN Created on 26 Sep 1979
926-4773 6505-01-272-6053 6505-01-305-4523 6505-19-001-0341 6505-01-308-9409 6505-01-153-3832 6505-01
CAPSULES NDC00078-0079-05 Managed by United States NSN Created on 5 May 1987 Data Last Changed PAMELOR
PAMELOR 01-083-5987 Usp Nortriptyline Hydrochloride Capsules Quantity [CSCW]10Therapeutic Equivalent
6505-00-197-9381 6505-01-254-4150 6505-19-001-0342 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-308-9409
254-4150 6505-19-001-0342 6505-01-305-4523 6505-19-001-0341 6505-01-308-9409 https//www.nsnlookup.com
Restrictions 6505-01-308-9409
6505-01-308-9409 is a Usp Nortriptyline Hydrochloride Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-308-9409
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-308-9409
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-308-9409
- Part Number
- Manufacturer
- Status
- NDC00078-0078-06
- Manufacturer
- 04520 - Novartis Pharmaceuticals Corp. (Active)
- Primary Buy
- Primary Buy
- PAMELOR
- 04520 - Novartis Pharmaceuticals Corp. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-308-9409
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Capsule Type [AKJC]
- Any Acceptable
- Capsule Content Form [CQLS]
- Powder
- Active Medicament Medicinal Strength [AKJA]
- 50.000 Milligrams Nortriptyline Hydrochloride Active Ingredient
- Primary Container Type [CQCT]
- Box
- Capsule Primary Container Content Quantity [CYLZ]
- 100.000
- Total Primary Container Quantity [CSCW]
- 1
- Special Features [FEAT]
- Unit Dose; Packages Of Individually Blister-Sealed Capsules
Management Data 6505-01-308-9409
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Oct 1989
- Veterans Administration (VA)
- BX
- Subscribe
- BX
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Ea
- 00000000100EA
- K
NATO Stock Numbers Related to 6505-01-308-9409
Freight Information 6505-01-308-9409
6505-01-308-9409 has freight characteristics.. 6505-01-308-9409 has a variance between NMFC and UFC when transported by rail and the description should be consulted.